EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Compound heterozygous factor XI deficiency in a twin pregnancy with uterus didelphys: a case report

Mengmeng Sun, Hua Liao, Hongyan Liu, Yanxi Jia, Haiyan Yu

Frontiers in Pharmacology · 19.11.2026 · 17

DOI: 10.3389/fphar.2026.1987744 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.11.2026. Verfasst von Mengmeng Sun und 4 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Factor XI (FXI) deficiency is a rare autosomal recessive bleeding disorder that causes coagulopathy. While the implications of general coagulation dysfunction during pregnancy are recognized, reports on severe compound heterozygous FXI deficiency complicated by a uterus didelphys and a twin pregnancy are exceedingly rare. Case Presentation We herein present a 29-year-old woman with a monochorionic diamniotic twin pregnancy and a uterus didelphys who was admitted at 32 weeks and 3 days of gestation due to a prolonged APTT. Despite lacking prior clinical hemorrhagic symptoms, she was diagnosed with severe FXI deficiency driven by a compound heterozygous mutation in the F11 gene. Managed by a multidisciplinary team (MDT), she underwent an emergency cesarean section under general anesthesia at 36 weeks and 1 day, successfully delivering both infants. Her perioperative coagulation profile was optimized via intravenous fresh frozen plasma that targeted the clinical hemostasis rather than the absolute laboratory values. Diligent monitoring confirmed no abnormal postpartum hemorrhage (PPH), and the woman remained hemodynamically stable. Both premature infants subsequently developed necrotizing enterocolitis but fully recovered following comprehensive treatment.

Conclusion

The primary hazard associated with severe FXI deficiency is PPH, and there is often a lack of significant correlation between the severity of clinical bleeding and laboratory values. Therefore, the prenatal assessment and peripartum management of this rare coagulopathy pose significant challenges. Prompt MDT recognition, individualized intervention, and ongoing care for pregnant individuals affected by inherited bleeding disorders are thus crucial for optimizing maternal and neonatal health outcomes.

Zitieren

APA

Sun, M., Liao, H., Liu, H., Jia, Y., & Yu, H. (2026). Compound heterozygous factor XI deficiency in a twin pregnancy with uterus didelphys: a case report. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1987744

Vancouver

Sun M, Liao H, Liu H, Jia Y, Yu H. Compound heterozygous factor XI deficiency in a twin pregnancy with uterus didelphys: a case report. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1987744

BibTeX
@article{Sun2026,
  author = {Sun, Mengmeng and Liao, Hua and Liu, Hongyan and Jia, Yanxi and Yu, Haiyan},
  title = {Compound heterozygous factor XI deficiency in a twin pregnancy with uterus didelphys: a case report},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1987744}
}
Kostenlos starten →